These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21867837)

  • 1. Homocysteine and reclassification of cardiovascular disease risk.
    Veeranna V; Zalawadiya SK; Niraj A; Pradhan J; Ference B; Burack RC; Jacob S; Afonso L
    J Am Coll Cardiol; 2011 Aug; 58(10):1025-33. PubMed ID: 21867837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
    Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
    Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.
    Shah N; Parikh V; Patel N; Patel N; Badheka A; Deshmukh A; Rathod A; Lafferty J
    Int J Cardiol; 2014 Feb; 171(3):390-7. PubMed ID: 24388541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
    Park CS; Ihm SH; Yoo KD; Kim DB; Lee JM; Kim HY; Chung WS; Seung KB; Kim JH
    Am J Cardiol; 2010 May; 105(9):1284-8. PubMed ID: 20403480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
    Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
    Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study.
    Elias-Smale SE; Wieberdink RG; Odink AE; Hofman A; Hunink MG; Koudstaal PJ; Krestin GP; Breteler MM; van der Lugt A; Witteman JC
    Eur Heart J; 2011 Aug; 32(16):2050-8. PubMed ID: 21606087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III.
    Badheka AO; Patel N; Tuliani TA; Rathod A; Marzouka GR; Zalawadiya S; Deshmukh A; Moscucci M; Cohen MG
    Am J Med; 2013 Apr; 126(4):319-326.e2. PubMed ID: 23415052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lone mothers are at higher risk for cardiovascular disease compared with partnered mothers. Data from the National Health and Nutrition Examination Survey III (NHANES III).
    Young LE; Cunningham SL; Buist DS
    Health Care Women Int; 2005 Aug; 26(7):604-21. PubMed ID: 16126603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III).
    Badheka AO; Patel NJ; Grover PM; Shah N; Singh V; Deshmukh A; Mehta K; Chothani A; Hoosien M; Rathod A; Savani GT; Marzouka GR; Gupta S; Mitrani RD; Moscucci M; Cohen MG
    Am J Cardiol; 2013 Sep; 112(6):805-10. PubMed ID: 23764245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).
    Nasir K; Budoff MJ; Wong ND; Scheuner M; Herrington D; Arnett DK; Szklo M; Greenland P; Blumenthal RS
    Circulation; 2007 Aug; 116(6):619-26. PubMed ID: 17646582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
    Cummings DM; King DE; Mainous AG; Geesey ME
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults.
    Zalawadiya SK; Gunasekaran PC; Bavishi CP; Veeranna V; Panaich S; Afonso L
    Eur J Prev Cardiol; 2015 May; 22(5):673-9. PubMed ID: 24699336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
    Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
    JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
    Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
    Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Dhangana R; Murphy TP; Pencina MJ; Zafar AM
    Atherosclerosis; 2011 May; 216(1):174-9. PubMed ID: 21414621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Electrocardiogram-Based Risk Equation for Incident Cardiovascular Disease From the National Health and Nutrition Examination Survey.
    Shah AJ; Vaccarino V; Janssens AC; Flanders WD; Kundu S; Veledar E; Wilson PW; Soliman EZ
    JAMA Cardiol; 2016 Oct; 1(7):779-786. PubMed ID: 27487404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.